[EN] USP19 INHIBITORS FOR USE IN THERAPY<br/>[FR] INHIBITEURS D'USP19 DESTINÉS À ÊTRE UTILISÉS EN THÉRAPIE
申请人:ALMAC DISCOVERY LTD
公开号:WO2020115500A1
公开(公告)日:2020-06-11
Provided are USP19 inhibitors, methods of treating obesity, metabolic syndrome and/or diabetes using the USP19 inhibitor compounds, as well as those compounds for use in methods of treating obesity, metabolic syndrome and/or diabetes. Also provided are methods of treating muscular atrophy, for example cachexia or sarcopenia with USP19 inhibitor compounds, plus those compounds for use in methods of treating muscular atrophy.